[New data on the action of intensain in coronary and myocardial insufficiency].
D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D001158:Arteries; D001783:Blood Flow Velocity; D001792:Blood Platelets / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001916:Brachial Artery; D006328:Cardiac Catheterization; D002306:Cardiac Volume / Q000187:drug effects; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D003374:Coumarins / Q000627:therapeutic use*; D004285:Dogs; D006016:Glycolates / Q000627:therapeutic use*; D006325:Heart Atria; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles; D006801:Humans; D007275:Injections, Intravenous; D010100:Oxygen / Q000097:blood; D011877:Radionuclide Imaging; D012039:Regional Blood Flow / Q000187:drug effects; D012413:Rubidium; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014680:Veins
D003374:Coumarins; D006016:Glycolates; D014665:Vasodilator Agents; D012413:Rubidium; D010100:Oxygen
Novye dannye o deĭstvii intensaina pri koronarnoĭ i miokardial'noĭ nedostatochnosti.